Skip To Main Content
Shashank Hambarde on Muck Rack

Shashank Hambarde

As seen in: Wiley Online Library, Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shashank

Contact Shashank, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Inhibition of mitochondrial NADH:ubiquinone oxidoreductase by spinning oscillating magnetic fields causes toxicity in cancer cells

|
By Shashank Hambarde, Arvind Pandey, David Baskin, Translational Biomagnetics
| Wiley Online Library Verified
Conflicts of interest S. A. Helekar and D. S. Baskin are listed as inventors on US and international patent applications filed by Houston Methodist Hospital on the technology underlying the device used in this study. The technology is licensed to OncoMAGNETx, Inc. Helekar and Baskin own stock in OncoMAGNETx, and Helekar has received honorariums from the company. The other authors have no disclosures to report.
Open in Who Shared Issue with article?

EXO5-DNA structure and BLM interactions direct DNA resection critical for ATR-dependent replication restart

|
By Shashank Hambarde, Chi-Lin Tsai, Raj K. Pandita
| Cell Press Verified
Alexandrov L.B. Kim J. Haradhvala N.J. Huang M.N. Tian Ng A.W. Wu Y. Boot A. Covington K.R. Gordenin D.A. Bergstrom E.N. et al. PCAWG Mutational Signatures Working Group; PCAWG Consortium The repertoire of mutational signatures in human cancer. Nature. 2020; 578: 94-101 Ali S. Zhang Y. Zhou M. Li H. Jin W. Zheng L. Yu X. Stark J.M. Weitzel J.N. Shen B. Functional deficiency of DNA repair gene EXO5 results in androgen-induced genomic instability and prostate tumorigenesis. Oncogene.
Open in Who Shared Issue with article?
See all 2 articles